Reese Pharmaceutical Company
United States
Due-diligence reportFind an accredited testing lab and confirm its scope covers your product and methods.
Reese Pharmaceutical Company is a dietary supplement manufacturer in the United States, certified to NSF/ANSI 455-2 and NSF/ANSI 455-4 GMP, with 1 manufacturing facility on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. Listed dosage forms: tablets.
- Phone
- 631-249-5130
- Facilities listed
- 1
- Last checked
Dosage forms
As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.
Certified facilities
Manufacturing (1)
14 EngineersLane, Farmingdale, NY 11735, United States
Facility operated as: PHARBEST PHARMACEUTICALS, INC.
- Coating
- Dry Formulation
- Mixing
- Packaging/Labeling Operation
- Packaging/Labeling Operation - Bulk Packaging
- Quality Unit Operations
- Tablet Compression
- Warehousing
How Reese Pharmaceutical Company compares
Among the 769 manufacturers we list, as of our last check.
- One of 228 tablet manufacturers we list in the United States. All tablet manufacturers in the USA
FDA recall records
FDA lists 2 recalls matching the name Reese Pharmaceutical Company, as of .
Class II · Could cause temporary or reversible health problems
Reported
Closed by FDA
The label does not list "Sodium" in the ingredient statement.
openFDA record2 products, first listed: Berry Flavor Immune Support Dietary Supplement Effervescent Tablets 10 Tablets/bottle. Product is sold under the following brand names: Discount Drug Mart UPC…
See all 2 products
- Berry Flavor Immune Support Dietary Supplement Effervescent Tablets 10 Tablets/bottle. Product is sold under the following brand names: Discount Drug Mart UPC 0 93351 01230 3; Good Neighbor Pharmacy UPC 0 87701 41330 8; Hyvee UPC 0 75450 09537 1; Kinray Preferred Plus UPC 0 23513 01010 6; Live Better UPC 0 41310 62998 7; Meijer UPC 7 08820 15073 7; Premier Value UPC 8 40986 02972 1; QC UPC 6 35515 96938 4; Rite Aid UPC 0 11822 95098 5; Shopko UPC 4 00114 22672 1; ShopRite UPC 0 41190 22784 6; Top Care UPC 0 36800 40632 2 & UPC 0 36800 40632 2; Western Family UPC 0 15400 12657 1 & Winco UPC 0 70552 24153 4.
- Orange Flavor Immune Support Dietary Supplement Effervescent Tablets 10 Tablets/bottle. Product is sold under the following brand names: Best Choice UPC 0 70038 60863 9 & UPC 0 70038 60863 9; Discount Drug Mart UPC 0 93351 00909 9; Freds Mart UPC 0 84579 12451 0; Good Neighbor Pharmacy UPC 0 87701 40672 0; Health Accents UPC 7 25439 95738 0; Health Mart UPC 0 52569 14073 4; Hyvee UPC 0 75450 06187 1; Kinray Preferred Plus UPC 0 23513 81512 1; Leader UPC 0 96295 13167 3 & UPC 0 96295 12239 8; Live Better UPC 0 41310 62997 0; Meijer UPC 7 08820 15072 0; Premier Value UPC 8 40986 01982 1; QC UPC 6 35515 95513 4; Reese UPC 0 23513 81512 1; Rite Aid UPC 0 11822 45092 8; Select Brand UPC 0 15127 02433 4; Shopko UPC 4 00125 10186 4; ShopRite UPC 0 41190 22785 3; Top Care UPC 0 36800 38123 0 & UPC 0 36800 38123 0; Western Family UPC 0 15400 12656 4 & Winco UPC 0 70552 24154 1.
Class III · Unlikely to cause health problems
Reported
Closed by FDA
The finished product label on the Cranberry supplement does not include Calcium. Users of the product may be unaware of the Calcium in the supplement. Additionally the amount per serving as written on the product label is incorrect and should be 500mg, not 900mg.
openFDA recordProduct: Good Neighbor Pharmacy Cranberry Tablets, Cranberry Supplement 450mg. Urinary Health. Tablets are packed in a labeled carton, 50 tablets per carton. Distribut…
Full product description
- Good Neighbor Pharmacy Cranberry Tablets, Cranberry Supplement 450mg. Urinary Health. Tablets are packed in a labeled carton, 50 tablets per carton. Distributed by Amerisource Bergen 1300 Morris Drive Chesterbrook, PA 19087.
We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check
FDA inspections
FDA lists 2 food or dietary supplement inspections at facilities matching Reese Pharmaceutical Company, from 2018 to 2021, as of . Both found conditions the firm was left to correct.
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Farmingdale, New York
Listed by FDA as Pharbest Pharmaceuticals, Inc.
2 citations posted:
- Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
- Specifications met - verify; finished batch (21 CFR 111.75(c))
Full citation text
Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
You did not establish product specifications for the identity, purity, strength and composition of the finished dietary supplement.
Specifications met - verify; finished batch (21 CFR 111.75(c))
You did not verify that your finished batch of dietary supplement meets product specifications for identity, purity, strength and composition.
FEI 3005382247
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Farmingdale, New York
Listed by FDA as Pharbest Pharmaceuticals, Inc.
10 citations posted:
- Specifications - component identity (21 CFR 111.70(b)(1))
- Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
- Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
- Reserve sample container-closure contamination,deterioration (21 CFR 111.83(b)(1))
See all 10 citations
Specifications - component identity (21 CFR 111.70(b)(1))
You did not establish an identity specification for each component.
Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
You did not establish product specifications for the identity, purity, strength and composition of the finished dietary supplement.
Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.
Reserve sample container-closure contamination,deterioration (21 CFR 111.83(b)(1))
Your reserve sample of a dietary supplement that was distributed to be packaged and labeled was not held using a container-closure system that provides essentially the same characteristics to protect against contamination or deterioration as the one in which it was distributed for packaging and labeling elsewhere.
Defined areas of adequate size for operations (21 CFR 211.42(c))
The separate or defined areas and control systems necessary to prevent contamination or mix-ups are deficient.
Calibration/Inspection/Checking not done (21 CFR 211.68(a))
Routine inspection and checking of electronic equipment is not performed according to a written program designed to assure proper performance.
Reports of Analysis (Components) (21 CFR 211.84(d)(2))
Reports of analysis from component suppliers are accepted in lieu of testing each component for conformity with all appropriate written specifications, without performing at least one specific identity test on each component and establishing the reliability of the supplier's analyses through appropriate validation of the supplier's test results at appropriate intervals.
Control procedures to monitor and validate performance (21 CFR 211.110(a))
Control procedures are not established which monitor the output and validate the performance of those manufacturing processes that may be responsible for causing variability in the characteristics of in-process material and the drug product.
Adequate number of batches on stability (21 CFR 211.166(b))
An adequate number of batches of each drug product are not tested to determine an appropriate expiration date.
Reserve samples identified, representative, stored (21 CFR 211.170(b))
Reserve drug product samples are not appropriately identified, representative of each lot or batch of drug product and retained and stored under conditions consistent with product labeling.
FEI 3005382247
We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check
What we checked, and what we didn’t
Confirmed from NSF’s public listing
Last checked
- NSF/ANSI 455-2 GMP certification
- NSF/ANSI 455-4 GMP certification
- 1 facility address
- Dosage forms in the certified scope
- Operations listed for each facility
Not verified by us
- Minimum order quantity (MOQ): the smallest order they accept
- Lead times and current capacity
- Prices
- Other certifications, like organic, kosher, halal or NSF Certified for Sport
- Whether they’re taking new clients
- Conditions inside the facility. We don’t visit or audit facilities.
Ask about these in your quote request. How we verify
Other tablet manufacturers in the United States
NSF lists 5 tablet facilities, including one in Tempe, AZ
Tempe, AZ, United States21stcenturyvitamins.com
- Capsules
- Gummies
- Softgels
- Tablets
Operations:- Kitting
- Coating
- Tablet compression
- Encapsulation
NSF/ANSI 455-2checked Nov 19, 2026NSF lists 2 tablet facilities, including one in Happauge, NY
Happauge, NY, United Statesazpharmaceutical.com
- Powders
- Tablets
Operations:- Tablet compression
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026NSF lists a tablet facility in Garden Grove, CA
Garden Grove, CA, United Statespackaging.com
- Capsules
- Gummies
- Powders
- Softgels
- Tablets
NSF/ANSI 455-2checked Nov 19, 2026Access Business Group, LLC
USDA OrganicNSF lists a tablet facility in Ada, MI
Ada, MI, United Statesamway.com
- Capsules
- Powders
- Softgels
- Tablets
Operations:- Kitting
- Coating
- Tablet compression
- Encapsulation
- +1 more
NSF/ANSI 455-2checked Nov 19, 2026NSF lists a tablet facility in Gilbert, AZ
Gilbert, AZ, United Statesadeptlifesciences.com
- Capsules
- Liquids
- Powders
- Tablets
Operations:- Liquid formulation
- Tablet compression
- Encapsulation
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026ADH Health Products, Inc.
USDA OrganicNSF lists a tablet facility in Congers, NY
Congers, NY, United Statesadhhealth.com
- Capsules
- Oils
- Powders
- Tablets
Operations:- Coating
- Tablet compression
- Encapsulation
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026